...
首页> 外文期刊>ACS nano >Near-Infrared Emission CuInS/ZnS Quantum Dots: All-in-One Theranostic Nanomedicines with Intrinsic Fluorescence/Photoacoustic Imaging for Tumor Phototherapy
【24h】

Near-Infrared Emission CuInS/ZnS Quantum Dots: All-in-One Theranostic Nanomedicines with Intrinsic Fluorescence/Photoacoustic Imaging for Tumor Phototherapy

机译:近红外发射CuInS / ZnS量子点:带有固有荧光/光声成像技术的肿瘤肿瘤光疗多合一治疗肿瘤纳米药物。

获取原文
获取原文并翻译 | 示例
           

摘要

Many theranostic nanomedicines (NMs) have been fabricated by packaging imaging and therapeutic moieties together. However, concerns about their potential architecture instability and pharmacokinetic complexity remain major obstacles to their clinical translation. Herein, we demonstrated the use of CuInS/ZnS quantum dots (ZCIS QDs) as "all-in-one" theranostic nanomedicines that possess intrinsic imaging and therapeutic capabilities within a well-defined nanostructure. ZCIS QDs were exploited for multispectral optical tomography (MSOT) imaging and synergistic PTT/PDT therapy. Due to the intrinsic ZCIS QDs fluorescence/MSOT imaging ability of the ZCIS QDs, their size-dependent distribution profiles were successfully visualized at tumor sites in vivo. Our results showed that the smaller nanomedicines (ZCIS NMs-25) have longer tumor retention times, higher tumor uptake, and deeper tumor penetration than the larger nanomedicines (ZCIS NMs-80). The ability of ZCIS QDs to mediate photoinduced tumor ablation was also explored. Our results verified that under a single 660 nm laser irradiation, the ZCIS NMs had simultaneous inherent photothermal and photodynamic effects, resulting in high therapy efficacy against tumors. In summary, the ZCIS QDs as "all-in-one" versatile nanomedicines allow high therapeutic efficacy as well as noninvasively monitoring tumor site localization profiles by imaging techniques and thus hold great potential as precision theranostic nanomedicines.
机译:通过将成像和治疗部分包装在一起,可以制造出许多治疗治疗纳米药物(NMs)。但是,对其潜在结构不稳定和药代动力学复杂性的担忧仍然是其临床翻译的主要障碍。在这里,我们演示了使用CuInS / ZnS量子点(ZCIS QDs)作为“多合一”治疗神经病纳米药物,这些药物在明确定义的纳米结构内具有固有的成像和治疗能力。 ZCIS QD被用于多光谱光学层析成像(MSOT)成像和PTT / PDT协同治疗。由于ZCIS QD具有固有的ZCIS QD荧光/ MSOT成像能力,因此可以在体内肿瘤部位成功观察到它们的大小依赖性分布图。我们的结果表明,与较大的纳米药物(ZCIS NMs-80)相比,较小的纳米药物(ZCIS NMs-25)具有更长的肿瘤保留时间,更高的肿瘤吸收率和更深的肿瘤穿透力。还探讨了ZCIS QD介导光诱导的肿瘤消融的能力。我们的结果证实,在单个660 nm激光照射下,ZCIS NMs同时具有固有的光热和光动力效应,从而对肿瘤具有很高的治疗功效。总之,作为“多合一”多功能纳米药物的ZCIS QD不仅具有很高的治疗功效,而且通过成像技术可以无创地监测肿瘤部位的定位,因此具有作为精确的治疗性纳米治疗药物的巨大潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号